Back to Journals » Journal of Blood Medicine » Volume 12

Efficacy, Safety and Pharmacokinetic Results of a Phase III, Open-Label, Multicenter Study with a Plasma-Derived Von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Pediatric Patients <12 Years of Age with Hemophilia A (SWIFTLY-HA Study)

Total article views   HTML views PDF downloads Totals
6,447 Dovepress* 6,123+ 515 6,638
PubMed Central* 324 102 426
Totals 6,447 617 7,064
*Since 21 June 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 1 2

View citations on PubMed Central and Google Scholar